Interactions of the nonsedating antihistamine loratadine with a Kv1.5- type potassium channel cloned from human heart

Molecular Pharmacology

Volumn 52, Issue 2, 1997, Pages 314-322

  Lacerda, Antonio E ^a   Roy, Mary Louise ^a   Lewis, Eric W ^b   Rampe, David ^b  

^a MetroHealth System ^*  (United States)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; DRUG METABOLITE; LORATADINE; POTASSIUM CHANNEL; POTASSIUM ION;

ANIMAL CELL; ARRHYTHMOGENESIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL;

EID: 0030852667     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.2.314     Document Type: Article

References (30)

1. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian gambit: a new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 84:1831-1851 (1991).
2. Anumonwo, J. M. B., L. C. Freeman, W. M. Kwok, and R. S. Kass. Potassium channels in the heart: electrophysiology and pharmacological regulation. Cardiovasc. Drug Rev. 9:299-316 (1991).
3. Kr, potassium channel. Cell 81:299-307 (1995).
4. Roberds, S. L., K. M. Knoth, S. Po, A. Blair, P. B. Bennett, R. P. Hartshorne, D. J. Snyders, and M. M. Tamkun. Molecular biology of the voltage-gated potassium channels of the cardiovascular system. J. Cardiovasc. Electrophysiol. 4:68-80 (1993).
5. + channel subunits in adult rat heart: relation to functional channels? Circ. Res. 77:361-369 (1995).
6. + channel current. Circ. Res. 73:210-216 (1993).
7. Wang, Z., B. Fermini, and S. Nattel. Sustained depolarization-induced outward current in human atrial myocytes: evidence for a novel delayed rectifier potassium current similar to Kv1.5 cloned channel currents. Circ. Res. 73:1061-1076 (1993).
8. + channel protein in explanted cardiac tissue. J. Clin. Invest. 96:282-292 (1995).
9. Davies, A. J., V. Harindra, A. McEwan, and R. R. Ghose. Cardiotoxic effect with convulsions in terfenadine overdose. Br. Med. J. 298:325 (1989).
10. Wiley, J. F., M. L. Gelber, F. M. Henretig, C. C. Wiley, S. Sandhu, and J. Loiselle. Cardiotoxic effects of astemizole overdose in children. J. Pediatr. 120:799-802 (1992).
11. Woosley, R. L., Y. Chen, J. P. Freiman, and R. A. Gillis. Mechanism of the cardiotoxic actions of terfenadine. JAMA 268:1532-1536 (1993).
12. 1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ. Res. 76:110-119 (1995).
13. + channel cloned from human heart. Mol. Pharmacol. 44:1240-1245 (1993).
14. Roy, M.-L., R. Dumaine, and A. M. Brown. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 94:817-823 (1996).
15. Woosley, R. L. Cardiac actions of antihistamines. Annu. Rev. Pharmacol. Toxicol. 36:233-252 (1996).
16. Good, A. P., R. Rockwood, and P. Schad. Loratadine and ventricular tachycardia. Am. J. Cardiol. 74:207 (1994).
17. Possible arrhythmias due to loratadine? More help please. Aust. Adv. Drug React. Bull. 15:3 (1996).
18. Hamill, O. P., A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth. Improved patch clamp techniques for high resolution current recording from cells and cell free membrane patches. Pflueg. Arch. Eur. J. Physiol. 391: 85-100 (1981).
19. VanDongen, A. M. J. A new algorithm for idealizing single ion channel data containing multiple unknown conductance levels. Biophys. J. 70: 1303-1315 (1996).
20. Colquhoun, D., and F. J. Sigworth. Fitting and statistical analysis of single channel records, in Single-Channel Recording (B. Sakmann and E. Neher, eds.). Plenum Press, New York, 483-587 (1995).
21. + currents in human atrium and in cells expression a Kv1.5-type cloned channel. J. Pharmacol. Exp. Ther. 271:444-449 (1995).
22. Hilbert, J., E. Radwanski, R. Weglein, V. Luc, G. Perentesis, S. Symchowicz, and N. Zampaglione. Pharmacokinetics and dose proportionality of loratadine. J. Clin. Pharmacol. 27:694-698 (1987).
23. Snyders, D. J., M. M. Tamkun, and P. B. Bennett. A rapidly activating and slowly inactivating potassium channel cloned from human heart: functional analysis after stable mammalian cell culture expression. J. Gen. Physiol. 101:513-543 (1993).
24. Yang, T., C. Prakash, D. M. Roden, and D. J. Snyders. Mechanism of block of a human cardiac potassium channel by terfenadine racemate and its enantiomers. Br. J. Pharmacol. 115:267-274 (1995).
25. Colquhoun, D., and A. G. Hawkes. The principles of the stochastic interpretation of ion channel mechanisms, in Single Channel Recording (B. Sakmann and E. Neher, eds.). Plenum Press, New York, 397-482 (1995).
26. Malayev, A. A., D. J. Nelson, and L. H. Philipson. Mechanism of clofilium block of the human Kv1.5 delayed rectifier potassium channel. Mol. Pharmacol. 47:198-205 (1995).
27. Johnson, R., J. Christensen, and C.-C. Lin. Sensitive gas-liquid Chromatographic method for the determination of loratadine and its major active metabolite, descarboethoxyloratadine, in human plasma using a nitrogen-phosphorus detector. J. Chromatogr. 657:125-131 (1994).
28. Hilbert, J., V. Moritzen, A. Parks, E. Radwanski, G. Perentesis, S. Symchowicz, and N. Zampaglione. The pharmacokinetics of loratadine in normal geriatric volunteers. J. Int. Med. Res. 16:50-60 (1988).
29. Woosley, R., and W. R. Darrow. Analysis of potential adverse drug reactions: a case of mistaken identity. Am. J. Cardiol. 74:208-209 (1994).
30. Haria, M., A. Fitton, and D. H. Peters. Loratadine: a reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs 48:617-637 (1994).